MEDICLIN Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
MEDICLIN Stock Forecast and Price Target
MEDICLIN has an average price target of 5.10€ recently offered by notable experts for 2024, which would represent a potential upside of approximately 80.85% from the last closing price in May, 2024 if reached. This potential increase is based on a high estimate of 5.10€ and a low estimate of 5.10€. Even if you are not interested in MED stock, you should still be aware of its competitors.
80.85% Upside
MEDICLIN Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, MEDICLIN's Price has grown by 100.00%, rising from 0.00€ to 0.00€. For next year, analysts predict Fair Value of 14.60€, which would mean an increase of 100.00%. Over the next seven years, experts predict that MEDICLIN's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| SAP Stock Forecast | SAP | Outperform |
14
|
169.70€ | 171.58€ | 14.91% |
| DTE Stock Forecast | Deutsche Telekom | Outperform |
10
|
21.49€ | 25.56€ | 25.64% |
| ALV Stock Forecast | Allianz | Outperform |
10
|
266.60€ | 267.63€ | 3.71% |
| DAI Stock Forecast | Daimler | Outperform |
5
|
70.94€ | 79.04€ | 20.52% |
| BMW Stock Forecast | Bayerische Motoren Werke | Hold |
7
|
102.45€ | 110.22€ | 8.35% |
MEDICLIN Revenue Forecast for 2023 - 2025 - 2030
In the last two years, MEDICLIN's Revenue has grown by 8.56%, rising from 661.81€M to 718.48€M. For next year, analysts predict Revenue of 751.24€M, which would mean an increase of 4.56%. Over the next seven years, experts predict that MEDICLIN's Revenue will grow at a rate of 4.11%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| VOW3 Stock Forecast | Volkswagen | Outperform |
7
|
115.15€ | 149.63€ | 21.58% |
| DPW Stock Forecast | Deutsche Post | Outperform |
11
|
39.26€ | 49.21€ | 17.80% |
| BAS Stock Forecast | BASF | Outperform |
12
|
49.16€ | 49.50€ | 13.91% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| IFX Stock Forecast | Infineon Technologies | Buy |
11
|
32.72€ | 44.51€ | 34.47% |
| ADS Stock Forecast | adidas | Hold |
11
|
226.40€ | 185.29€ | 0.49% |
| DB1 Stock Forecast | Deutsche Börse | Outperform |
9
|
181.15€ | 194.24€ | 12.06% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| EOAN Stock Forecast | E.ON | Outperform |
13
|
12.40€ | 12.76€ | 20.97% |
| BEI Stock Forecast | Beiersdorf | Outperform |
17
|
140.55€ | 137.41€ | 6.01% |
| DBK Stock Forecast | Deutsche Bank | Hold |
9
|
15.01€ | 13.28€ | 4.93% |
MEDICLIN EBITDA Forecast for 2023 - 2025 - 2030
MEDICLIN's EBITDA has grown In the last two years, rising from 20.67€M to 36.93€M – a growth of 78.66%. In the next year, analysts believe that EBITDA will reach 95.17€M – an increase of 157.70%. For the next seven years, experts predict that MEDICLIN's EBITDA will grow at a rate of 156.58%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| HEN3 Stock Forecast | Henkel AG & Co. KGaA | Hold |
16
|
74.46€ | 71.63€ | 0.73% |
| HNR1 Stock Forecast | Hannover Rück | Hold |
16
|
232.40€ | 193.83€ | 1.12% |
| BAYN Stock Forecast | Bayer | Hold |
5
|
27.35€ | 45.15€ | 9.69% |
MEDICLIN EBIT Forecast for 2023 - 2025 - 2030
MEDICLIN's EBIT has seen impressive growth In the last two years, rising from -9.26€M to 10.34€M – a growth of 211.66%. In the next year, analysts believe that EBIT will reach 41.32€M – an increase of 299.61%. For the next seven years, the forecast is for EBIT to grow by 308.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| RWE Stock Forecast | RWE | Buy |
15
|
32.63€ | 51.40€ | 44.44% |
| HEI Stock Forecast | HeidelbergCement | Outperform |
17
|
94.64€ | 88.88€ | 10.95% |
| CBK Stock Forecast | Commerzbank | Outperform |
7
|
13.96€ | 14.05€ | 8.88% |
MEDICLIN EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, MEDICLIN's EPS has grown by 100.00%, rising from -0.19€ to 0.00€. For next year, analysts predict EPS of 0.37€, which would mean an increase of 100.00%. Over the next seven years, experts predict that MEDICLIN's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| FRE Stock Forecast | Fresenius SE & Co. KGaA | Outperform |
18
|
27.97€ | 38.63€ | 23.35% |
| CON Stock Forecast | Continental | Outperform |
16
|
60.84€ | 89.38€ | 40.53% |
| FME Stock Forecast | Fresenius Medical Care AG & Co... | Hold |
18
|
39.60€ | 41.13€ | -2.78% |